At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Triple-blind, Placebo Controlled, Parallel Clinical Trial to Investigate the Effect of Pollen Extracts on Menopausal Symptoms in Healthy Women.
In Brief
A Phase 2 clinical trial evaluating Graminex WSPE, Graminex LSPE, and 1 other intervention for Menopausal Women. Currently recruiting, targeting 120 participants across 1 site.
Detailed Summary
The goal of this study is to investigate the effect of pollen extracts on menopausal symptoms in healthy women The main question it aims to answer is: What is the difference in change in severity of menopausal symptoms as assessed by the total Menopause Rating Scale (MRS) score from baseline at Week 36 between Graminex Water Soluble Pollen Extract (WSPE), Lipid Soluble Pollen Extract (LSPE), and Placebo? Participants will be asked to complete the MRS assessment tool to rate their menopausal symptoms while receiving either WSPE, LSPE, or Placebo.
Study Details
Timeline
Interventions
Graminex Water Soluble Pollen Extract is standardized to 6% amino acids.
Graminex Lipid Soluble Pollen Extract is standardized to 7% phytosterols.
Placebo